About ErgoNex Pharma
Provider of products for novel and typically underserved indications. The company focused on the clinical development and commercialization of terguride for the treatment of distinct orphan diseases. It also identifies and develops therapeutic use of existing drugs in new disease areas.
Missing: ErgoNex Pharma's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: ErgoNex Pharma's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
ErgoNex Pharma Frequently Asked Questions (FAQ)
When was ErgoNex Pharma founded?
ErgoNex Pharma was founded in 2004.
Where is ErgoNex Pharma's headquarters?
ErgoNex Pharma's headquarters is located at Rütistrasse 20, Appenzell.
What is ErgoNex Pharma's latest funding round?
ErgoNex Pharma's latest funding round is Series B.
How much did ErgoNex Pharma raise?
ErgoNex Pharma raised a total of $6.74M.
Who are the investors of ErgoNex Pharma?
Investors of ErgoNex Pharma include High Tech Private Equity.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.